Clinical Trial Update: Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring dalpiciclib with or without entinostat and letrozole for HR+/HER2- early breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)
• Entinostat (entinostat)
• Letrozole (letrozole)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING